	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	11/07/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-070888	Time of broadcast: 08:52 08:51:21

Report of Periodic or Interim Report

Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Form 10-Q

ORAMEDPHARMINC_10Q_20190711_isa.pdf

Link of EDGAR Filing: _________


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 25/06/2019
Address: 142 W 57th St. 11th floor 0 , New York 10019 New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com Company site: www.oramed.com

Previous names of reporting entity:

Name of the Signatory: GABAY AVRAHAM Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Hi-Tech Park, Givat Ram 2/4 , Jerusalem 92390 Telephone: 052-5660004 Facsimile: 02-5660004 E-mail: Avi@oramed.com 2
USA